Companies Mentioned

Boston Scientific Corp.

Category
Title
Summary
Date
Commentaries
Patent Law

In Boston Scientific v. Cordis, 554 F.3d 982 (Fed. Cir. 2009), the Court of Appeals for the Federal Circuit overturned both the PTO Examiner and the district court trial jury in invalidating Boston Scientific’s patent claims due to invalidity. Specifically, the appellate court determined that prior art disclosed all elements…
Posted:
04/2/2009
Summaries
Patent Law >
New Settlements and Verdicts

Saffran is the owner of the ’760 patent,  entitled “Method and Apparatus for Managing Macromolecular Distribution.” He accused BSC of infringing his patent by engaging in the business of manufacturing, assembling, and selling drug-eluting stents, including, but not limited to, Taxus Express, a Paclitaxel-Eluting Coronary Stent System. In its answer,…
Date of ruling:
03/20/2009
Summaries
Patent Law >
New Judicial Opinions

Defendants-appellants Cordis Corp. and Johnson & Johnson, Inc. (collectively “Cordis”) appealed from the judgment of the district court denying a motion for a new trial and judgment as a matter of law (“JMOL”) following a jury verdict of infringement of claim 8 of the ’536 patent owned by plaintiffs-appellees Boston…
Date of ruling:
01/15/2009
Summaries
Patent Law >
New Judicial Opinions

Plaintiff-appellant Jang is the named inventor of the ’021 and ’743 patents, relating to the design or architecture of intravascular stents, tube-shaped mesh devices used to treat certain forms of cardiac disease. In this contract case, Jang alleged that defendant-appellee Boston Scientific Corporation (“Boston Scientific”) and Scimed Life Systems Incorporated…
Date of ruling:
07/15/2008
Summaries
Patent Law >
New Settlements and Verdicts

Bruce N. Saffran, Ph.D., M.D. is the patent owner of the ’760 patent entitled “Method and Apparatus for Managing Macromolecular Distribution.” He accused BSC of infringing his patent by engaging in the business of manufacturing, assembling, and selling drug-eluting stents, including, but not limited to, Taxus Express, a Paclitaxel-Eluting Coronary…
Date of ruling:
07/9/2008
Summaries
Patent Law >
New Settlements and Verdicts

Plaintiff Medtronic Vascular, Inc., Medtronic USA, Ins., Medtronic, Inc., and Medtronic Vascular Galway, Ltd. (“Medtronic”) are engaged in medical technology to treat conditions such as diabetes, heart disease, neurological disorders, and vascular illnesses. Defendant Boston Scientific Corp., Scimed Life Systems Inc., Boston Scientific Scimed, Inc. (“Boston Scientific”) are engaged in…
Date of ruling:
05/27/2008
The most advanced document                
         management system in the world.

Only $59 / person / month
FeaturesLawLoop Demo
FeaturesWelcome to the Future
Play LawLoop Demo